{"id":6274,"date":"2015-10-07T14:46:14","date_gmt":"2015-10-07T12:46:14","guid":{"rendered":"https:\/\/celonpharma.com\/?p=6274"},"modified":"2017-11-17T09:33:42","modified_gmt":"2017-11-17T09:33:42","slug":"celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/","title":{"rendered":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)"},"content":{"rendered":"<p><strong>On 26 August 2015, Celon Pharma S.A. signed another agreement with the National Centre for Research and Development for the co-financing of a project entitled: &#8220;New treatment for psychotic disorders and Huntington&#8217;s disease with special focus on cognitive deficits&#8221; (NoteSzHD) as part of the STRATEGMED programme.<\/strong><\/p>\n<p>The funds obtained under the agreement will allow Celon Pharma S.A., the leader of the scientific and business consortium, to continue work on the project together with five other consortium members: The Nencki Institute of Experimental Biology PAS in the Polish Academy of Sciences, the Mossakowski Medical Research Centre in the Polish Academy of Sciences, Institute of Pharmacology of the Polish Academy of Sciences, the Medical University of Lodz and the Poznan University of Medical Sciences.<br \/>\nThe total cost of the project is PLN 40,279,820 and the co-financing allocated to the Consortium amounts to 26,730,836.<\/p>\n<p>The main objective of the STRATEGMED programme is to obtain fundamental progress in the fight against lifestyle diseases and regenerative medicine based on results of research and development works.<\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-4851\" src=\"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg\" alt=\"logo_sm_ostateczne_d\" width=\"300\" height=\"242\" srcset=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg 300w, https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_sm_ostateczne_d-768x620.jpg 768w, https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_sm_ostateczne_d-1024x827.jpg 1024w, https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_sm_ostateczne_d.jpg 1351w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p style=\"text-align: center;\"><a href=\"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_ncbir.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-4850\" src=\"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_ncbir-300x182.jpg\" alt=\"logo_ncbir\" width=\"300\" height=\"182\" srcset=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_ncbir-300x182.jpg 300w, https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_ncbir-768x466.jpg 768w, https:\/\/celonpharma.com\/wp-content\/uploads\/2015\/10\/logo_ncbir.jpg 945w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 26 August 2015, Celon Pharma S.A. signed another agreement with the National Centre for Research and Development for the co-financing of a project entitled: &#8220;New treatment for psychotic disorders and Huntington&#8217;s disease with special focus on cognitive deficits&#8221; (NoteSzHD) as part of the STRATEGMED programme. The funds obtained under the agreement will allow Celon<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/\" title=\"ReadCelon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-6274","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"On 26 August 2015, Celon Pharma S.A. signed another agreement with the National Centre for Research and Development for the co-financing of a project entitled: &#8220;New treatment for psychotic disorders and Huntington&#8217;s disease with special focus on cognitive deficits&#8221; (NoteSzHD) as part of the STRATEGMED programme. The funds obtained under the agreement will allow CelonRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2015-10-07T12:46:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-11-17T09:33:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)\",\"datePublished\":\"2015-10-07T12:46:14+00:00\",\"dateModified\":\"2017-11-17T09:33:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/\"},\"wordCount\":185,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-zawartosc\\\/uploads\\\/2015\\\/10\\\/logo_sm_ostateczne_d-300x242.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/\",\"name\":\"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-zawartosc\\\/uploads\\\/2015\\\/10\\\/logo_sm_ostateczne_d-300x242.jpg\",\"datePublished\":\"2015-10-07T12:46:14+00:00\",\"dateModified\":\"2017-11-17T09:33:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-zawartosc\\\/uploads\\\/2015\\\/10\\\/logo_sm_ostateczne_d-300x242.jpg\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-zawartosc\\\/uploads\\\/2015\\\/10\\\/logo_sm_ostateczne_d-300x242.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma","og_description":"On 26 August 2015, Celon Pharma S.A. signed another agreement with the National Centre for Research and Development for the co-financing of a project entitled: &#8220;New treatment for psychotic disorders and Huntington&#8217;s disease with special focus on cognitive deficits&#8221; (NoteSzHD) as part of the STRATEGMED programme. The funds obtained under the agreement will allow CelonRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/","og_site_name":"Celon Pharma","article_published_time":"2015-10-07T12:46:14+00:00","article_modified_time":"2017-11-17T09:33:42+00:00","og_image":[{"url":"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg","type":"","width":"","height":""}],"author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)","datePublished":"2015-10-07T12:46:14+00:00","dateModified":"2017-11-17T09:33:42+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/"},"wordCount":185,"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/","url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/","name":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD) - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg","datePublished":"2015-10-07T12:46:14+00:00","dateModified":"2017-11-17T09:33:42+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg","contentUrl":"https:\/\/celonpharma.com\/wp-zawartosc\/uploads\/2015\/10\/logo_sm_ostateczne_d-300x242.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-concluded-another-agreement-with-the-national-centre-for-research-and-development-ncrd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma S.A. concluded another agreement with the National Centre for Research and Development (NCRD)"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/6274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=6274"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/6274\/revisions"}],"predecessor-version":[{"id":12085,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/6274\/revisions\/12085"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=6274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=6274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=6274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}